Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of the study is to compare safety and efficacy of stem cell mobilization using G-CSF (filgrastim) alone vs. intermediate-dose cytosine arabinoside plus G-CSF in multiple myeloma patients.
Epistemonikos ID: f2e41c51d01e088fa71a083d6968a209c3200bc0
First added on: May 11, 2024